TheraSplice
TheraSplice is developing a precision oncology platform and products. The company has several targets under development in prostate, lung, breast, and liver cancer with the goal of initiating biomarker stratified clinical trials.
Company Details
Company type
Year founded
2022
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Products under development
Splice-switching oligonucleotides and small molecule drugs